StonvexLoading…
StonvexCore line items from FANG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2023 2023-06-30 | Q1 2023 2023-03-31 | Annual 2022 2022-12-31 | Q3 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $3.80B | $1.90B | $9.57B | $7.56B |
Operating Income | $2.02B | $1.02B | $6.51B | $5.25B |
Net Income | $1.27B | $712.00M | $4.39B | $3.38B |
EPS (Diluted) | $6.95 | $3.88 | $24.61 | $18.99 |
Total Assets | $29.00B | $27.59B | $26.21B | $23.84B |
Total Liabilities | $11.38B | $11.47B | $10.52B | $9.29B |
Cash & Equivalents | $18.00M | $46.00M | $157.00M | $27.00M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 179.22M | 181.60M | 179.84M | 175.63M |